DK0475290T3 - Et nyt biologisk aktivt peptid stammende fra frø (frø CNP) - Google Patents

Et nyt biologisk aktivt peptid stammende fra frø (frø CNP)

Info

Publication number
DK0475290T3
DK0475290T3 DK91115079T DK91115079T DK0475290T3 DK 0475290 T3 DK0475290 T3 DK 0475290T3 DK 91115079 T DK91115079 T DK 91115079T DK 91115079 T DK91115079 T DK 91115079T DK 0475290 T3 DK0475290 T3 DK 0475290T3
Authority
DK
Denmark
Prior art keywords
cnp
seeds
seed
biologically active
active peptide
Prior art date
Application number
DK91115079T
Other languages
Danish (da)
English (en)
Inventor
Hisayuki Matsuo
Kenji Kangawa
Naoto Minamino
Original Assignee
Hisayuki Matsuo
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisayuki Matsuo, Suntory Ltd filed Critical Hisayuki Matsuo
Application granted granted Critical
Publication of DK0475290T3 publication Critical patent/DK0475290T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
DK91115079T 1990-09-07 1991-09-06 Et nyt biologisk aktivt peptid stammende fra frø (frø CNP) DK0475290T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2238294A JP2977159B2 (ja) 1990-09-07 1990-09-07 カエル由来新規生理活性ペプチド（カエルｃｎｐ）

Publications (1)

Publication Number Publication Date
DK0475290T3 true DK0475290T3 (da) 1999-08-30

Family

ID=17028056

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91115079T DK0475290T3 (da) 1990-09-07 1991-09-06 Et nyt biologisk aktivt peptid stammende fra frø (frø CNP)

Country Status (8)

Country Link
US (1) US5336759A (fr)
EP (1) EP0475290B1 (fr)
JP (1) JP2977159B2 (fr)
AT (1) ATE175211T1 (fr)
DE (1) DE69130695T2 (fr)
DK (1) DK0475290T3 (fr)
ES (1) ES2127189T3 (fr)
GR (1) GR3029632T3 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
BRPI0203172B8 (pt) 2001-09-28 2021-05-25 Nakao Kazuwa composição farmacêutica para acondroplasia
CN1960758B (zh) 2004-03-31 2014-10-22 中外制药株式会社 关节炎的治疗剂或预防剂
EP1743653A4 (fr) 2004-03-31 2009-09-30 Kazuwa Nakao Composition pour augmenter la stature
EP1759001B1 (fr) 2004-04-21 2011-04-13 Enobia Pharma Inc. Conjugues de delivrance dans l'os et procede d'utilisation pour le ciblage de proteines vers l'os
EP2190450A2 (fr) * 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Utilisation de l'hormone de concentration de la mélanine et de la met-enkephaline comme agents thérapeutiques
CA2823066A1 (fr) 2010-12-27 2012-07-05 Alexion Pharma International Sarl Compositions contenant des peptides natriuretiques et leurs methodes d'utilisation
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
MX2017007392A (es) 2014-12-05 2019-01-24 Alexion Pharma Inc Tratamiento de convulsiones con fosfatasa alcalina recombinante.
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
AU2016308624B2 (en) 2015-08-17 2022-06-23 Alexion Pharmaceuticals, Inc. Manufacturing of alkaline phosphatases
JP6868617B2 (ja) 2015-09-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
EP3368062A4 (fr) 2015-10-30 2019-07-03 Alexion Pharmaceuticals, Inc. Méthodes de traitement de la craniosynostose chez un patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
EP3436052A4 (fr) 2016-04-01 2019-10-09 Alexion Pharmaceuticals, Inc. Traitement d'une faiblesse musculaire à l'aide de phosphatases alcalines
EP3436020A4 (fr) 2016-04-01 2019-12-25 Alexion Pharmaceuticals, Inc. Méthodes de traitement de l'hypophosphatasie chez les adolescents et les adultes
US10988744B2 (en) 2016-06-06 2021-04-27 Alexion Pharmaceuticals, Inc. Method of producing alkaline phosphatase
US11116821B2 (en) 2016-08-18 2021-09-14 Alexion Pharmaceuticals, Inc. Methods for treating tracheobronchomalacia
EP3600383A4 (fr) 2017-03-31 2020-10-28 Alexion Pharmaceuticals, Inc. Méthodes de traitement de l'hypophosphatasie (hpp) chez l'adulte et l'adolescent
EP3773684A1 (fr) 2018-03-30 2021-02-17 Alexion Pharmaceuticals, Inc. Production de glycoprotéines
EP4291224A1 (fr) 2021-02-12 2023-12-20 Alexion Pharmaceuticals, Inc. Polypeptides de phosphatase alcaline et leurs méthodes d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2544929B2 (ja) * 1987-06-17 1996-10-16 第一化学薬品 株式会社 新規生理活性ペプチド
US5114923A (en) * 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
ATE175211T1 (de) 1999-01-15
ES2127189T3 (es) 1999-04-16
DE69130695T2 (de) 1999-06-10
GR3029632T3 (en) 1999-06-30
JPH04120095A (ja) 1992-04-21
US5336759A (en) 1994-08-09
JP2977159B2 (ja) 1999-11-10
EP0475290B1 (fr) 1998-12-30
EP0475290A1 (fr) 1992-03-18
DE69130695D1 (de) 1999-02-11

Similar Documents

Publication Publication Date Title
DK0475290T3 (da) Et nyt biologisk aktivt peptid stammende fra frø (frø CNP)
DK0475291T3 (da) Fra kylling afledt biologisk aktivt peptid (kylling CNP)
FI924453A (fi) Nya 9-amino-7-(substituerad)-6-demetyl-6-deoxitetracykliner
FR13C0013I2 (fr) Analogues de peptide 2 du type glucagon
ES2155844T3 (es) Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios, utiles como antagonistas de opiaceos.
FI924454A0 (fi) Nya 7-substituerad-9-(substituerad amino)-6-demetyl-6-deoxitetracykliner
FI870113A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5,6-substioitujenN-(substituoitu-fenyyli)-2-pyrimidiiniamiinien valmistamiseksi
ATE86971T1 (de) Verfahren zur herstellung von 5-amino-4hydroxyvalerians|ure-derivaten.
ATE245435T1 (de) Totalsynthese des amino hip analogen von didemnin a
ATE155485T1 (de) Bpc-peptide, ihre herstellung und verwendung
NO895028L (no) Ny chimerisk transformerende vekstfaktor-beta.
DE69027063D1 (de) Enantioselektive Synthese von Antifolaten
HUT51295A (en) Process for producing peptidalcohol derivatives of anticoagulant activity
ATE47880T1 (de) Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung.
ATE13424T1 (de) Verfahren zur herstellung von pyrrolen.
ATE190630T1 (de) Angiotensin-ii typ-1 rezeptor und dessen herstellung
DE59602774D1 (de) Verfahren zur Herstellung von 3.3.5-Trimethylcyclohexanon
ATE133709T1 (de) Peroxidase-gen von mikrobischem ursprung
ES2058067T3 (es) Proceso para la produccion de 2,6-didesoxi-2-fluoro-l-talopiranosa y sus derivados.
DE69331216D1 (de) Planze resistent gegen mindestens zwei viren und dessen preparation
ES2059766T3 (es) Precursor de prostaglandinas y su produccion.
ATE92077T1 (de) Enzymhemmer und methode zu dessen herstellung.
ATE37865T1 (de) Verfahren zur herstellung von monochloressigsaeure aus glykolsaeure.
MY102413A (en) N-phenyl-n-carboxythioureas and their use in the control of pests
IT8423089A0 (it) Solubilizzazione di ossigeno mediante adsorbimento dell'ossigeno nei fanghi biologici degli impianti di depurazione a fanghi attivi.